Abstract:Anaplastic carcinoma of the pancreas (ACP) is a rare and aggressive variant of pancreatic ductal adenocarcinoma (PDAC). Several studies have attempted to characterize this subtype through case series or single case reports; however, ACP remains underrecognized by cytopathologists in particular, and often lumped under the umbrella of classic PDAC. Here, we review the most up to date data that literature provides about ACP, to bring familiarity with this entity to the cytopathology practice, and to elucidate the… Show more
“…It is worth mentioning that recently, we described a variant of primary anaplastic carcinoma of the pancreas with signet ring cell morphology . In the reported case, the neoplastic cells were enlarged with ample vacuolated cytoplasm, and hyperchromatic nuclei with irregular contours and prominent nucleoli, admixed with pleomorphic mononuclear cells and multinucleated giant cells . Other scenarios that can mimic signet ring cells carcinoma in the pancreas include, but are not limited to, metastatic SRCC of another organ to the pancreas (Figure ), melanoma with signet ring cell features and signet ring cell lymphoma .…”
Section: Discussionmentioning
confidence: 68%
“…It is worth mentioning that recently, we described a variant of primary anaplastic carcinoma of the pancreas with signet ring cell morphology . In the reported case, the neoplastic cells were enlarged with ample vacuolated cytoplasm, and hyperchromatic nuclei with irregular contours and prominent nucleoli, admixed with pleomorphic mononuclear cells and multinucleated giant cells .…”
Primary signet ring cell carcinoma of the pancreas (PSRCCP) is an extremely rare diagnosis that has not been extensively studied in literature. Primary and metastatic neoplasms to the pancreas may exhibit cytomorphological similarities to signet ring cells, posing diagnostic challenges. In this article, we review PSRCCP and provide a study of several primary pancreatic neoplasms that may mimic the appearance of PSRCCP upon cytopathology evaluation, shedding light on the existence of this dilemma, and helping cytopathologists in navigating similar scenarios in their practice. K E Y W O R D S clear cell features, cytopathology, FNA, primary signet ring cell carcinoma of the pancreas, signet ring cell features
“…It is worth mentioning that recently, we described a variant of primary anaplastic carcinoma of the pancreas with signet ring cell morphology . In the reported case, the neoplastic cells were enlarged with ample vacuolated cytoplasm, and hyperchromatic nuclei with irregular contours and prominent nucleoli, admixed with pleomorphic mononuclear cells and multinucleated giant cells . Other scenarios that can mimic signet ring cells carcinoma in the pancreas include, but are not limited to, metastatic SRCC of another organ to the pancreas (Figure ), melanoma with signet ring cell features and signet ring cell lymphoma .…”
Section: Discussionmentioning
confidence: 68%
“…It is worth mentioning that recently, we described a variant of primary anaplastic carcinoma of the pancreas with signet ring cell morphology . In the reported case, the neoplastic cells were enlarged with ample vacuolated cytoplasm, and hyperchromatic nuclei with irregular contours and prominent nucleoli, admixed with pleomorphic mononuclear cells and multinucleated giant cells .…”
Primary signet ring cell carcinoma of the pancreas (PSRCCP) is an extremely rare diagnosis that has not been extensively studied in literature. Primary and metastatic neoplasms to the pancreas may exhibit cytomorphological similarities to signet ring cells, posing diagnostic challenges. In this article, we review PSRCCP and provide a study of several primary pancreatic neoplasms that may mimic the appearance of PSRCCP upon cytopathology evaluation, shedding light on the existence of this dilemma, and helping cytopathologists in navigating similar scenarios in their practice. K E Y W O R D S clear cell features, cytopathology, FNA, primary signet ring cell carcinoma of the pancreas, signet ring cell features
“…As a subtype of pancreatic ductal adenocarcinoma, PSRCC is very rare [8]. To our best knowledge, only 21 cases were reported in the literature [8,[19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35]. The value of chemotherapy was still unclear for the lack of high-quality clinical evidence and large samples of multicenter clinical studies.…”
Background
Primary pancreatic signet ring cell carcinoma (PSRCC), an extremely rare histologic variant of pancreatic cancer, has a poor prognosis. This study aimed to investigate the prognostic value of chemotherapy in PSRCC.
Methods
Patients with PSRCC between 2000 and 2019 were identified using the Surveillance Epidemiology and End Results (SEER) database. The main outcomes in this study were cancer-specific survival (CSS) and overall survival (OS). The baseline characteristics of patients were compared using Pearson’s Chi-square test. Kaplan-Meier analysis was used to generate the survival curves. Least absolute shrinkage and selection operator (LASSO), univariate and multivariate Cox regression models, and Random Survival Forest model were used to analyze the prognostic variables for OS and CSS. The variance inflation factors (VIFs) were used to analyze whether there was an overfitting problem.
Results
A total of 588 patients were identified. Chemotherapy was an independent prognostic factor for OS and CSS, and significantly associated with OS (HR = 0.33, 95% CI = 0.27–0.40, P <0.001) and CSS (HR = 0.32, 95% CI = 0.26–0.39, P <0.001).
Conclusions
Chemotherapy showed beneficial effects on OS and CSS in patients with PSRCC and should be recommended in clinical practice.
“…On the contrary, spindle cells tend to arrange in a storiform pattern and to be more uniform, ovoid to spindle shaped. Furthermore, areas of infiltrating ductal adenocarcinoma at the periphery of the lesions, squamous differentiation, and areas of phagocytic activity are frequently observed[ 73 , 81 , 82 ]. Although this bizarre morphology, electron microscopy, and above all, immunohistochemistry analysis have demonstrated the epithelial origin of UC neoplastic cells.…”
Exocrine pancreatic neoplasms represent up to 95% of pancreatic cancers (PCs) and are widely recognized among the most lethal solid cancers, with a very poor 5-year survival rate of 5%-10%. The remaining < 5% of PCs are neuroendocrine tumors that are usually characterized by a better prognosis, with a median overall survival of 3.6 years. The most common type of PC is pancreatic ductal adenocarcinoma (PDAC), which accounts for roughly 85% of all exocrine PCs. However up to 10% of exocrine PCs have rare histotypes, which are still poorly understood. These subtypes can be distinguished from PDAC in terms of pathology, imaging, clinical presentation and prognosis. Additionally, due to their rarity, any knowledge regarding these specific histotypes is mostly based on case reports and a small series of retrospective analyses. Therefore, treatment strategies are generally deduced from those used for PDAC, even if these patients are often excluded or not clearly represented in clinical trials for PDAC. For these reasons, it is essential to collect as much information as possible on the management of PC, as assimilating it with PDAC may lead to the potential mistreatment of these patients. Here, we report the most significant literature regarding the epidemiology, typical presentation, possible treatment strategies, and prognosis of the most relevant histotypes among rare PCs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.